Methanol Chemicals Company (2001) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
26 Nov, 2025Executive summary
Reported a net loss of SAR 570 million for the nine months ended 30 September 2025, with accumulated losses exceeding half of capital and current liabilities surpassing current assets by SAR 388.3 million.
Material uncertainty exists regarding the ability to continue as a going concern, contingent on a planned rights issue and other liquidity measures.
Significant impairment loss of SAR 336.4 million recognized due to adverse market conditions and management's decision to cease support for certain subsidiaries.
Financial highlights
Revenue for the nine-month period was SAR 477.8 million, down from SAR 531.6 million year-over-year.
Gross profit dropped to SAR 21.0 million from SAR 74.1 million year-over-year.
Operating loss widened to SAR 536.5 million from SAR 56.4 million year-over-year.
Net loss for the period was SAR 570.0 million, compared to SAR 82.0 million in the prior year.
Basic and diluted loss per share for the nine months was SAR (7.56), compared to SAR (1.14) year-over-year.
Outlook and guidance
Management is pursuing a capital increase through a rights issue, expected to be completed in Q2 2026, and is also considering a capital decrease to extinguish accumulated losses.
Liquidity improvement measures include loan restructuring, additional short-term facilities, and operational efficiencies.
The ability to continue as a going concern depends on successful execution of these measures and regulatory approvals.
Latest events from Methanol Chemicals Company
- H1 2025 saw a SR 529.3 million net loss and major impairment, raising going concern risks.2001
Q2 202518 Aug 2025 - Net loss narrowed to SAR 81.98m as two major acquisitions were consolidated.2001
Q3 202413 Jun 2025 - Net loss narrowed and two key acquisitions completed, with gross profit up despite lower revenue.2001
Q2 202413 Jun 2025 - Net loss deepened and liquidity risks persist as Chemanol pursues a major rights issue.2001
Q1 20256 Jun 2025 - Net loss deepens to SAR 286.2 million in 2024 amid acquisitions and liquidity challenges.2001
Q4 20245 Jun 2025